Cargando…
Identification of novel neuroendocrine-specific tumour genes
Neuroendocrine tumours (NETs) comprise a heterogenous group of malignancies with an often unpredictable course, and with limited treatment options. Thus, new diagnostic, prognostic, and therapeutic markers are needed. To shed new lights into the biology of NETs, we have by cDNA transcript profiling,...
Autores principales: | Hofsli, E, Wheeler, T E, Langaas, M, Lægreid, A, Thommesen, L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2570516/ https://www.ncbi.nlm.nih.gov/pubmed/18827820 http://dx.doi.org/10.1038/sj.bjc.6604565 |
Ejemplares similares
-
Identification of novel growth factor-responsive genes in neuroendocrine gastrointestinal tumour cells
por: Hofsli, E, et al.
Publicado: (2005) -
Identification of Endoglin as an epigenetically regulated tumour-suppressor gene in lung cancer
por: O'Leary, K, et al.
Publicado: (2015) -
Putative tumour suppressor gene necdin is hypermethylated and mutated in human cancer
por: De Faveri, L E, et al.
Publicado: (2013) -
Gene expression profiling of human ovarian tumours
por: Biade, S, et al.
Publicado: (2006) -
Gene expression profiling of noninvasive primary urothelial tumours using microarrays
por: Aaboe, M, et al.
Publicado: (2005)